Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.
Kaehler KC, Blome C, Forschner A, Gutzmer R, Haalck T, Heinzerling L, Kornek T, Livingstone E, Loquai C, Maul LV, Lang BM, Schadendorf D, Stade B, Terheyden P, Utikal J, Wagner T, Hauschild A, Garbe C, Augustin M.
Kaehler KC, et al. Among authors: maul lv.
Medicine (Baltimore). 2016 Nov;95(46):e5375. doi: 10.1097/MD.0000000000005375.
Medicine (Baltimore). 2016.
PMID: 27861370
Free PMC article.